Literature DB >> 27177647

A Contemporary Evaluation of the Cause of Death and Long-Term Quality of Life After Total Pancreatectomy.

Wenchuan Wu1,2, Rebecca Dodson1, Martin A Makary1, Matthew J Weiss1, Kenzo Hirose1, John L Cameron1, Nita Ahuja1, Timothy M Pawlik1, Christopher L Wolfgang1, Jin He3.   

Abstract

OBJECTIVE: Total pancreatectomy (TP) may be considered for diffuse disease of the pancreas. However, the quality of life (QOL) implications of TP have not been well studied in the contemporary era. We report the QOL and cause of death after TP.
METHODS: 186 patients underwent TP between 2000 and 2013. The 100 who were still alive at last follow-up were sent a questionnaire including the Short Form-36 (SF-36), the Audit of Diabetes Dependent QoL (ADD QoL), and the European Organization for Research and Treatment in Cancer Pancreas 26 (EORTC-PAN-26). The cause of death was determined for the 86 patients who were dead at last follow-up.
RESULTS: While the majority of deaths of the 86 patients were cancer related (n = 65), only one patient died of diabetes complications. Among the 100 surviving patients, the median follow-up was 5.9 years. Among the 36 patients who responded to the survey, every patient required pancreatic enzymes and insulin; four patients required seven total hospitalizations for hypoglycemia. The SF-36 survey indicated a worse QOL in six domains compared with a national population matched with age and gender. However, only physical and emotional domains were decreased compared with self-matched preoperative state (p < 0.01 and p < 0.05, respectively). The ADD QoL survey showed an overall decrease in diabetes-related QoL (p < 0.01). When compared to other types of insulin-dependent diabetes, no significant difference in QoL were found in 14 of 19 domains. The EORTC-PAN-26 survey demonstrated that more than 50 % of patients had moderate to severe changes in three of seven domains.
CONCLUSIONS: Mortality from diabetic complications following TP is uncommon. The decreasing QoL after TP is comparable to self-matched preoperative assessment or insulin-dependent diabetes from other causes. Accounting for the overall health changes, TP should be considered in carefully selected patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27177647     DOI: 10.1007/s00268-016-3552-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

1.  Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30.

Authors:  P M Fayers
Journal:  Eur J Cancer       Date:  2001-07       Impact factor: 9.162

Review 2.  Total pancreatectomy: indications, operative technique, and postoperative sequelae.

Authors:  David G Heidt; Charles Burant; Diane M Simeone
Journal:  J Gastrointest Surg       Date:  2007-02       Impact factor: 3.452

3.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

4.  Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.

Authors:  Sushanth Reddy; Christopher L Wolfgang; John L Cameron; Frederic Eckhauser; Michael A Choti; Richard D Schulick; Barish H Edil; Timothy M Pawlik
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

5.  Changing indications for a total pancreatectomy: perspectives over a quarter of a century.

Authors:  Max Almond; Keith J Roberts; James Hodson; Robert Sutcliffe; Ravi Marudanayagam; John Isaac; Paolo Muiesan; Darius Mirza
Journal:  HPB (Oxford)       Date:  2014-11-19       Impact factor: 3.647

6.  Pylorus-preserving total pancreatectomy. Early and late results.

Authors:  M Wagner; K Z'graggen; C E Vagianos; C A Redaelli; F Holzinger; C Sadowski; C Kulli; H Zimmermann; H U Baer; M W Büchler
Journal:  Dig Surg       Date:  2001       Impact factor: 2.588

7.  Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up?

Authors:  Brian J Billings; John D Christein; William S Harmsen; Jeffrey R Harrington; Suresh T Chari; Florencia G Que; Michael B Farnell; David M Nagorney; Michael G Sarr
Journal:  J Gastrointest Surg       Date:  2005-11       Impact factor: 3.452

Review 8.  Management strategies for patients with hereditary pancreatic cancer.

Authors:  Teresa A Brentnall
Journal:  Curr Treat Options Oncol       Date:  2005-09

Review 9.  Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.

Authors:  W Cory Johnston; Helena M Hoen; Maria A Cassera; Pippa H Newell; Chet W Hammill; Paul D Hansen; Ronald F Wolf
Journal:  HPB (Oxford)       Date:  2015-12-21       Impact factor: 3.647

10.  Diabetic control after total pancreatectomy.

Authors:  P Jethwa; M Sodergren; A Lala; J Webber; J A C Buckels; S R Bramhall; D F Mirza
Journal:  Dig Liver Dis       Date:  2006-03-09       Impact factor: 4.088

View more
  7 in total

1.  Health-related quality of life in trauma patients at 12 months after injury: a prospective cohort study.

Authors:  Nobuichiro Tamura; Akira Kuriyama; Toshie Kaihara
Journal:  Eur J Trauma Emerg Surg       Date:  2018-08-22       Impact factor: 3.693

Review 2.  Pancreatic Nerve Sheath Tumors: a Single Institutional Series and Systematic Review of the Literature.

Authors:  Ammar A Javed; Michael J Wright; Alina Hasanain; Kevin Chang; Richard A Burkhart; Ralph H Hruban; Elizabeth Thompson; Elliot K Fishman; John L Cameron; Jin He; Christopher L Wolfgang; Matthew J Weiss
Journal:  J Gastrointest Surg       Date:  2019-04-02       Impact factor: 3.452

Review 3.  Familial pancreatic cancer: Concept, management and issues.

Authors:  Hiroyuki Matsubayashi; Kyoichi Takaori; Chigusa Morizane; Hiroyuki Maguchi; Masamichi Mizuma; Hideaki Takahashi; Keita Wada; Hiroko Hosoi; Shinichi Yachida; Masami Suzuki; Risa Usui; Toru Furukawa; Junji Furuse; Takamitsu Sato; Makoto Ueno; Yoshimi Kiyozumi; Susumu Hijioka; Nobumasa Mizuno; Takeshi Terashima; Masaki Mizumoto; Yuzo Kodama; Masako Torishima; Takahisa Kawaguchi; Reiko Ashida; Masayuki Kitano; Keiji Hanada; Masayuki Furukawa; Ken Kawabe; Yoshiyuki Majima; Toru Shimosegawa
Journal:  World J Gastroenterol       Date:  2017-02-14       Impact factor: 5.742

4.  Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.

Authors:  Michael Goggins; Kasper Alexander Overbeek; Randall Brand; Sapna Syngal; Marco Del Chiaro; Detlef K Bartsch; Claudio Bassi; Alfredo Carrato; James Farrell; Elliot K Fishman; Paul Fockens; Thomas M Gress; Jeanin E van Hooft; R H Hruban; Fay Kastrinos; Allison Klein; Anne Marie Lennon; Aimee Lucas; Walter Park; Anil Rustgi; Diane Simeone; Elena Stoffel; Hans F A Vasen; Djuna L Cahen; Marcia Irene Canto; Marco Bruno
Journal:  Gut       Date:  2019-10-31       Impact factor: 23.059

Review 5.  Perioperative Nutritional Aspects in Total Pancreatectomy: A Comprehensive Review of the Literature.

Authors:  Niccolò Furbetta; Annalisa Comandatore; Desirée Gianardi; Matteo Palmeri; Gregorio Di Franco; Simone Guadagni; Giovanni Caprili; Matteo Bianchini; Lorenzo Maria Fatucchi; Martina Picchi; Luca Bastiani; Giandomenico Biancofiore; Giulio Di Candio; Luca Morelli
Journal:  Nutrients       Date:  2021-05-22       Impact factor: 5.717

6.  Landscape of Health-Related Quality of Life in Patients With Early-Stage Pancreatic Cancer Receiving Adjuvant or Neoadjuvant Chemotherapy: A Systematic Literature Review.

Authors:  Teresa Macarulla; Andrew E Hendifar; Chung-Pin Li; Michele Reni; Hanno Riess; Margaret A Tempero; Amylou C Dueck; Marc F Botteman; Chinmay G Deshpande; Eleanor J Lucas; Do-Youn Oh
Journal:  Pancreas       Date:  2020-03       Impact factor: 3.243

7.  Systematic review of functional outcome and quality of life after total pancreatectomy.

Authors:  L Scholten; T F Stoop; M Del Chiaro; O R Busch; C van Eijck; I Q Molenaar; J H de Vries; M G Besselink
Journal:  Br J Surg       Date:  2019-09-10       Impact factor: 6.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.